Literature DB >> 6088654

Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications.

T Obayashi.   

Abstract

Preexposure of blood samples to perchloric acid permitted an accurate, quantitative measurement of endotoxin levels as low as 1 pg/ml using a colorimetric limulus test. Conventional chloroform and dilution-heating methods were unsatisfactory because of high residual nonspecific amidolytic activity and poor recovery. The normal peripheral plasma endotoxin level was less than 10 pg/ml when Escherichia coli 0111:B4 endotoxin was used as a reference. One nanogram in this assay was equivalent to 2.9 endotoxin units of USP reference standard endotoxin (E. coli 0113). High values were noted in portal venous blood and in cases of acute hepatitis, liver cirrhosis, strangulation ileus, pyothorax, lung abscess, diffuse panbronchiolitis, and pneumonia. Normal human plasma and serum exhibited a high capacity to inactivate added endotoxin. E. coli 0111:B4 and Salmonella minnesota 9700 were more susceptible to inactivation than Pseudomonas aeruginosa endotoxin. This inactivating activity was temperature dependent, was maximal between 37 degrees and 45 degrees C, and disappeared completely after heating plasma or serum to 56 degrees C for 30 minutes prior to the addition of endotoxin. The E. coli 0111:B4 endotoxin-inactivating activity of normal platelet-rich plasma, platelet-poor plasma, and serum, all at 37 degrees C, was 8.1 +/- 3.1, 11.7 +/- 4.5, and 15.2 +/- 4.9 micrograms/min/ml (mean +/- SD; n = 4), respectively. Endotoxin-inactivating activity was markedly decreased in plasma from patients with endotoxemia, but returned to normal with recovery from the underlying illness.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088654

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  33 in total

1.  Change in plasma endotoxin titres and endotoxin neutralizing activity in the perioperative period.

Authors:  T Imai; T Shiga; N Saruki; K Nishikawa; T Fujita; Y Morishita
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

Review 2.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

3.  Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation.

Authors:  T Miyata; I Yokoyama; S Todo; A Tzakis; R Selby; T E Starzl
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

4.  Release of penicillinase by Escherichia coli HB101 (pEAP31) accompanying the simultaneous release of outer-membrane components by Kil peptide.

Authors:  R Aono
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

5.  Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; I Takahashi; T Ikeda; K Otsuka; H Shimauchi; N Kasai; J Mashimo
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Endotoxemia and human liver transplantation.

Authors:  I Yokoyama; S Todo; T Miyata; R Selby; A G Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1989-10       Impact factor: 1.066

7.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

8.  Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

Authors:  S Kotani; H Takada; I Takahashi; T Ogawa; M Tsujimoto; H Shimauchi; T Ikeda; H Okamura; T Tamura; K Harada
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Changes in the blood endotoxin concentration after digestive surgery.

Authors:  Y Kokuba; A Nakao; H Takagi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  The ability of polymorphonuclear leukocytes to produce active oxygen in a model of peritonitis in rats.

Authors:  S C Shen; A Nakao; W Kishimoto; A Harada; T Nonami; M Nakano; H Takagi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.